bendamustine hydrochloride has been researched along with Erythema Nodosum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurung, R; Robertson, C; Vickers, MA | 1 |
| Jallad, B; Mawri, S; Nabi, S; Won, J | 1 |
2 other study(ies) available for bendamustine hydrochloride and Erythema Nodosum
| Article | Year |
|---|---|
Paraprotein associated syndrome treated successfully with chemotherapy.
Topics: Abdominal Pain; Antineoplastic Agents; Bendamustine Hydrochloride; Diagnosis, Differential; Erythema Nodosum; Female; Humans; Immunoglobulin M; Lymphocytosis; Middle Aged; Paraproteins; Patient Care Management; Rituximab; Schnitzler Syndrome; Treatment Outcome; Weight Loss | 2020 |
Leukaemia cutis after starting bendamustine: cause or coincidence?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Erythema Nodosum; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Male; Middle Aged; Rituximab; Skin; Vidarabine | 2015 |